Previous 10 | Next 10 |
Two sample Breakout Stocks for Week 7 with better than 10% short-term upside potential and a Dow stock pick. The negative Momentum Gauge® signal continues into 2022 without an MDA breakout buy signal in one of the worst starts to the stock market since 2008. Last week all pic...
Two sample Breakout Stocks for Week 6 with better than 10% short-term upside potential and a Dow stock pick. The negative Momentum Gauge® signal continues into 2022 without an MDA breakout buy signal in one of the worst starts to the stock market since 2008. Last week the pic...
Two sample Breakout Stocks for Week 52 with better than 10% short-term upside potential and a Dow stock pick. This past week, two stocks beat 10% peak gains in FLGT +19.1% and DYAI +13.8% with Momentum Gauge® values improving through the week. Following the Daily Momentum Gau...
Two sample Breakout Stocks for Week 51 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week, 1 stock beat 10% peak gains in BYFC +28.2% despite high negative Momentum Gauge® values from November continui...
Cardiff has one asset, onvansertib, a PLK1 inhibitor which has performed well in the clinic thus far in second line KRAS-mutated mCRC. Pfizer made a recent $15m investment and will get a first look at data. The response rate looks promising to date but the data is not yet mature. ...
Two sample Breakout Stocks for Week 50 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week 1 stock beat 10% peak gains in HIMX +13.2% despite high negative Momentum Gauge® values from November continuin...
Two sample Breakout Stocks for Week 49 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week 2 stocks beat 10% peak gains with VIR +39.9% and GRTS +26.5% despite very high negative Momentum Gauge® signals...
Prem Watsa’s 13F portfolio value decreased from $3.11B to $3.07B this quarter. Fairfax Financial’s largest three stakes are Atlas Corp., BlackBerry, and Resolute Forest Products. They together account for ~76% of the 13F assets. The 13F securities form a small portio...
Two sample Breakout Stocks for Week 48 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. Following the Daily Momentum Gauges® the portfolio is up +70.5% YTD despite a record high 26 weeks out 47 weeks this year in n...
CyrusOne (CONE) and CoreSite (COR) agreed to be acquired in deals valued at $15 billion and $10 billion, respectively. Data centers have been a significant area of growth over the last couple of decades. Ranked by colocation and data center revenues, CyrusOne and CoreSite are the ...
News, Short Squeeze, Breakout and More Instantly...
Trillium Therapeutics Inc. Company Name:
TRIL Stock Symbol:
NASDAQ Market:
Trillium Therapeutics Inc. Website:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that i...